ONE PLATFORM, ENDLESS POSSIBILITIES

Innovating immunotherapies, transforming tomorrow

Our ImmunoEngine platform combines deep immunology expertise with AI-driven technologies to decode the immune system at scale. From antigen discovery and target prioritization to drug design, we enable vaccine developers, biologics innovators, and pharma partners to build safer, more effective immune-based therapies.

For biologics developers

Discover differentiated, high-confidence targets for next-generation biologics with our proprietary AI-powered myNEO technologies.

Discover more →

For vaccine & T-cell developers

Unlock precise, high-immunogenic antigen discovery for immune-driven therapies with our proprietary AI-powered myNEO technologies.

Discover more →

For strategic partners

Explore our proprietary asset library of high-confidence immunotherapy targets available for partnering and licensing.

Discover more →

A modular platform powering immune-driven discovery

myNEO offers a suite of AI-driven technologies that supports target discovery, prioritization, and optimization across therapeutic modalities and disease areas. Each solution can be used independently or combined into an integrated end-to-end workflow.